Vanguard Group Inc. Acquires 272,787 Shares of agilon health, inc. (NYSE:AGL)

Vanguard Group Inc. lifted its stake in shares of agilon health, inc. (NYSE:AGL - Free Report) by 0.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 31,112,407 shares of the company's stock after acquiring an additional 272,787 shares during the quarter. Vanguard Group Inc. owned about 7.55% of agilon health worth $59,114,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in AGL. Oak Thistle LLC bought a new stake in agilon health in the fourth quarter worth about $25,000. Ieq Capital LLC bought a new stake in shares of agilon health in the 4th quarter worth approximately $26,000. Signaturefd LLC lifted its stake in agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares during the last quarter. Raymond James Financial Inc. acquired a new position in agilon health in the fourth quarter worth approximately $33,000. Finally, Symphony Financial Services Inc. grew its position in agilon health by 44.3% in the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company's stock worth $44,000 after buying an additional 7,058 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on AGL. Sanford C. Bernstein upgraded agilon health from a "market perform" rating to an "outperform" rating and lifted their target price for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Robert W. Baird dropped their target price on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research report on Tuesday. Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Royal Bank of Canada upped their price target on agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. Finally, Cowen reaffirmed a "hold" rating on shares of agilon health in a research note on Tuesday. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, agilon health presently has a consensus rating of "Hold" and a consensus price target of $4.60.

agilon health Stock Performance

NYSE:AGL traded down $1.84 during trading hours on Thursday, hitting $3.64. 6,048,138 shares of the company traded hands, compared to its average volume of 5,736,224. The firm has a 50-day moving average of $4.12 and a 200 day moving average of $3.11. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $7.73. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $1.50 billion, a price-to-earnings ratio of -3.87 and a beta of 0.38.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.